1. Home
  2. MCI vs CYRX Comparison

MCI vs CYRX Comparison

Compare MCI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Corporate Investors

MCI

Barings Corporate Investors

HOLD

Current Price

$18.00

Market Cap

362.0M

Sector

Finance

ML Signal

HOLD

CYRX

CryoPort Inc.

HOLD

Current Price

$9.95

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCI
CYRX
Founded
1971
1999
Country
United States
United States
Employees
N/A
1100
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
362.0M
419.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
MCI
CYRX
Price
$18.00
$9.95
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.94
AVG Volume (30 Days)
58.5K
399.7K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
8.46%
N/A
EPS Growth
N/A
156.22
EPS
1.82
1.40
Revenue
N/A
$176,177,000.00
Revenue This Year
N/A
$11.06
Revenue Next Year
N/A
$8.45
P/E Ratio
$9.86
$7.19
Revenue Growth
N/A
N/A
52 Week Low
$17.24
$5.21
52 Week High
$23.00
$11.45

Technical Indicators

Market Signals
Indicator
MCI
CYRX
Relative Strength Index (RSI) 40.75 71.24
Support Level $17.24 $9.18
Resistance Level $18.19 $10.23
Average True Range (ATR) 0.55 0.41
MACD 0.08 0.17
Stochastic Oscillator 47.23 90.91

Price Performance

Historical Comparison
MCI
CYRX

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: